View on Pubmed.gov 30505012 | View on doi.org 10.5114/reum.20...
Sleep disorders in patients with psoriatic arthritis and psoriasis.
- Department of Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Poland.
- Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Poland.
Abstract
OBJECTIVES
To assess and measure occurrence of sleep disorders in patients with psoriatic arthritis (PsA) and psoriasis (Ps).
MATERIAL AND METHODS
The study included 62 patients with psoriatic arthritis and 52 patients with psoriasis. The measurement of sleep quality was conducted using the Pittsburgh Sleep Quality Index (PSQI), the evaluation of fatigue by the fatigue subscale of the FACIT-F questionnaire and the patient's quality of life by the Health Assessment Questionnaire (HAQ). The psoriasis severity was determined using the Psoriasis Area Severity Index (PASI) and the activity of arthritis by the disease activity score of 28 joints (DAS 28). The Visual Analogue Scale (VAS) was used to assess the severity of pain.
RESULTS
Poor sleep quality was found in 67.7% of PsA patients, 57.7% in Ps patients and 14.6% within the control group. Sleeping disorders in patients with PsA and Ps were related to worse quality of life and intense fatigue. Methotrexate treatment was not related to sleeping disorders, but an improvement in sleep quality was observed in both PsA and Ps patients who were treated with anti TNF-α antibodies ( < 0.001 and = 0.032 respectively). Following the use of the linear regression model, the following factors worsen the sleep quality in PsA: pain ( = 0.462, < 0.001), tender joint count ( = 0.434, < 0.001), C-reactive protein (CRP) concentration ( = 0.391, < 0.001), patient's age ( = 0.284, = 0.003) and duration of psoriasis ( = 0.166, = 0.006). In Ps patients the factors were: severity of skin lesions ( = 0.329, < 0.001), duration of psoriasis ( = 0.290, = 0.004) and patient's age ( = 0.282, = 0.019).
CONCLUSIONS
Poor sleep quality in patients with PsA or Ps is a common symptom. Sleep disorders are more frequent in patients with PsA than in those with psoriasis.
References
Biol Psychiatry. 2016 Jul 1;80(1):40-52
Clin Rheumatol. 2018 Aug;37(8):2161-2168
Br J Dermatol. 2017 Oct;177(4):1052-1059
J Am Acad Dermatol. 2010 Jul;63(1):114-23
Cited by 44 citations (total)
Journal Article
Influence of Skin Subjective Symptoms on Sleep Quality in Patients with Cutaneous Disorders: A Study of 2871 Subjects.
Electronic publication date February 20, 2021
Bruno Halioua [...] Charles Taieb et al.
INTRODUCTION
Previous studies showed more sleep disturbance (SD) in patients with cutaneous disorders (CD). During CD, unpleasant subjective symptoms [USS], such...
Journal Article Scoping Review
Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review.
Electronic publication date October 29, 2022
Ilaria Controne [...] Giovanni Damiani et al.
Western diet may trigger sleep disorders and vice versa, but their single and mutual effects on systemic inflammatory diseases (i.e.,...
Conflict of interest statement
The authors declare no conflict of interest.
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •